Proteomics in Cardiovascular disease

被引：0

作者：

Gong, Miao ^{[1
,2
]}

Zhang, Yu ^{[1
,2
]}

Chen, Ning ^{[1
,2
]}

Ma, Lin-Lin ^{[1
,2
]}

Feng, Xu-Man ^{[1
,2
]}

Yan, Yu-Xiang ^{[1
,2
,3
]}

机构：

[1] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China

[2] Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China

[3] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 10 Xitoutiao, Beijing 100069, Peoples R China

来源：

CLINICA CHIMICA ACTA | 2024年 / 557卷

基金：

北京市自然科学基金; 中国国家自然科学基金;

关键词：

Proteomics; Cardiovascular disease; Diagnosis; Biomarker; ACUTE CORONARY SYNDROME; PULMONARY ARTERIAL-HYPERTENSION; SERUM-PROTEIN SIGNATURE; RISK-FACTORS; BIOMARKERS; DIAGNOSIS; HEART; IDENTIFICATION; DISCOVERY;

D O I：

10.1016/j.cca.2024.117877

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

This study focuses on recent advances in proteomics and provides an up-to-date use of this technology in identifying cardiovascular disease (CVD) biomarkers. A total of eight electronic databases (PubMed, EMBASE, Web of Science, Cochrane Library, Wanfang, Vip, Sinomed, and CNKI) were searched and five were used for integrative analysis of sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic ratio (DOR) and 1 secondary indicator area under the curve (AUC). This systematic review and integrative analysis summarized potential biomarkers previously identified by proteomics. The integrative analysis suggested that proteomics technology had high clinical value in CVD diagnosis. The findings provided new possible directions for the prevention or diagnosis of CVD.

引用

页数：8

共 50 条

[1] Proteomics and cardiovascular disease
Vivanco, F
López-Bescós, L
Tuñón, J
Egido, J
[J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (03): : 289 - 302
[2] Proteomics and cardiovascular disease: An update
Balestrieri, Maria Luisa
Giovane, Alfonso
Mancini, Francesco Paolo
Napoli, Claudio
[J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (06) : 555 - 572
[3] Proteomics of citrullination in cardiovascular disease
Fert-Bober, Justyna
Sokolove, Jeremy
[J]. PROTEOMICS CLINICAL APPLICATIONS, 2014, 8 (7-8) : 522 - 533
[4] Proteomics approach to the study of cardiovascular disease
Lee, Y
Kim, N
Kim, E
Han, J
[J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 178 - 178
[5] STEM CELL PROTEOMICS AND CARDIOVASCULAR DISEASE
Xu Qingbo
[J]. IFPT'6: PROGRESS ON POST-GENOME TECHNOLOGIES, PROCEEDINGS, 2009, : 7 - 7
[6] Proteomics strategies targeting biomarkers for cardiovascular disease
Scholten, Aden
Heck, Albert J. R.
[J]. ADVANCES IN CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, : 3 - 8
[7] Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics
Apple, Fred S.
Cullen, Louise
Felker, G. Michael
Ginsburg, Geoffrey
Morrow, David
[J]. CLINICAL CHEMISTRY, 2017, 63 (01) : 1 - 4
[8] Diagnostic biomarkers in cardiovascular disease: the proteomics approach
Doehner, Wolfram
[J]. EUROPEAN HEART JOURNAL, 2012, 33 (18) : 2249 - 2251
[9] Impact of Biomarkers, Proteomics, and Genomics in Cardiovascular Disease Introduction
Apple, Fred S.
Blankenberg, Stefan
Morrow, David A.
[J]. CLINICAL CHEMISTRY, 2012, 58 (01) : 1 - 2
[10] Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
Nurmohamed, Nick S.
Kraaijenhof, Jordan M.
Mayr, Manuel
Nicholls, Stephen J.
Koenig, Wolfgang
Catapano, Alberico L.
Stroes, Erik S. G.
[J]. EUROPEAN HEART JOURNAL, 2023, : 1594 - 1607

← 1 2 3 4 5 →